-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Purple Biotech, Maintains $33 Price Target

Benzinga·11/15/2024 19:44:17
Listen to the news
HC Wainwright & Co. analyst Emily Bodnar reiterates Purple Biotech (NASDAQ:PPBT) with a Buy and maintains $33 price target.